ARIYA Trademark

Trademark Overview


On Tuesday, October 23, 2018, a trademark application was filed for ARIYA with the United States Patent and Trademark Office. The USPTO has given the ARIYA trademark a serial number of 88165128. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 5, 2019. This trademark is owned by PureTech Health LLC. The ARIYA trademark is filed in the Pharmaceutical Products category with the following description:

Immunotherapeutic agents, namely, antibodies, vaccines, and pharmaceutical preparations thereof for the treatment of cancer and neurodegenerative, neurodevelopmental and cognitive disorders; Therapeutic agents for transport and delivery of small molecules and biologics to the lymphatic system; Exosome-based pharmaceutical preparations to facilitate the oral administration and delivery of therapeutic agents; pharmaceutical preparations for the modulation of lymphatic function in the brain for the treatment, prevention, and delayed onset of central nervous system disorders, Alzheimer's disease, Huntington's disease, age-associated cognitive decline and diseases associated with neurodegenerative, neurodevelopmental and cognitive disorders; Therapeutic agents for the treatment of fibrotic diseases, namely, interstitial lung disease, pulmonary fibrosis, lymphedema, sclerosis, and scleroderma
ariya

General Information


Serial Number88165128
Word MarkARIYA
Filing DateTuesday, October 23, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImmunotherapeutic agents, namely, antibodies, vaccines, and pharmaceutical preparations thereof for the treatment of cancer and neurodegenerative, neurodevelopmental and cognitive disorders; Therapeutic agents for transport and delivery of small molecules and biologics to the lymphatic system; Exosome-based pharmaceutical preparations to facilitate the oral administration and delivery of therapeutic agents; pharmaceutical preparations for the modulation of lymphatic function in the brain for the treatment, prevention, and delayed onset of central nervous system disorders, Alzheimer's disease, Huntington's disease, age-associated cognitive decline and diseases associated with neurodegenerative, neurodevelopmental and cognitive disorders; Therapeutic agents for the treatment of fibrotic diseases, namely, interstitial lung disease, pulmonary fibrosis, lymphedema, sclerosis, and scleroderma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePureTech Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02116

Trademark Events


Event DateEvent Description
Thursday, September 5, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 5, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION WRITTEN
Thursday, January 31, 2019ASSIGNED TO EXAMINER
Saturday, November 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 26, 2018NEW APPLICATION ENTERED IN TRAM